|119.43||-0.54 / -0.45%|
As of 4:14pm ET
|119.43||0.00 / 0.00%|
The 25 analysts offering 12-month price forecasts for Vertex Pharmaceuticals Inc have a median target of 130.00, with a high estimate of 200.00 and a low estimate of 85.00. The median estimate represents a +8.85% increase from the last price of 119.43.
The current consensus among 30 polled investment analysts is to Buy stock in Vertex Pharmaceuticals Inc. This rating has held steady since February, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.